The tweet was deleted by the author.
But we saved everything 🙂.
Rigel Pharmaceuticals announced that CEO Raul Rodriguez will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 3 at 8:45am ET in New York.
Investors and stakeholders can listen to the presentation via a live webcast, as shared by the company. This conference appearance gives Rigel Pharmaceuticals an opportunity to update the healthcare investment community on recent developments and future outlook.
Rigel Pharmaceuticals has recently participated in major industry events, inviting ASCO Annual Meeting attendees to discuss oncology advancements at booth 33080 in Chicago earlier this year. The company’s partner Kissei also filed a new drug application in Japan for olutasidenib to treat relapsed acute myeloid leukemia patients in a separate regulatory move. These initiatives come as Rigel continues to pursue opportunities for its pipeline in new markets and therapeutic areas.